cagrilintide and retatrutide stack retatrutide-and-cagrilintide-15mg-5mg Cagrilintide and Retatrutide for Men:

Escalation: Move to 4 mg weekly for Weeks 58, then 8 mg weekly for Weeks 912 [1]

For cagrilintide , the most significant trial programme involves its combination with semaglutide (CagriSema), investigated in the REDEFINE trial series

Both of these medications contain semaglutide, a synthetic version of the GLP-1 hormone, but they are prescribed at different doses depending on the patients medical needs

This has major implications for treatment planning

A generic version of Saxenda, liraglutide, is now available, which may make it more affordable than the brand-name medication as low as $20 per month with insurance and copay savings for eligible individuals

Restrictive eating disorders A joint advisory from obesity and nutrition societies notes that restrictive eating disorders are a general contraindication to GLP-1 use